ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy
Xiangling Xiao(Wuhan University), Jinfang Zhang(Wuhan University)
Cited by 75
Related Papers
USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy
|Nature Communications|2022|150
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy
|Cell chemical biology|2023|86
Oridonin inhibits gefitinib-resistant lung cancer cells by suppressing EGFR/ERK/MMP-12 and CIP2A/Akt signaling pathways
|International Journal of Oncology|2016|63
Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy
|Molecular Therapy|2025|15